Clinical Plenary #2

Journey Maps

Presentations

8:45 AM - 9:00 AM
Apr 29 2026
Washington, D.C.

Weight-dependent and independent effects of semaglutide in participants with MASH: secondary analysis of the phase 3 ESSENCE trial

Philip N Newsome, MD, PhD , Abstract Presenter
Hepatitis
MASLD